Latest news
Cullinan Therapeutics 3Q 2026: Revenue $0 Net loss $53.7M, EPS $(0.81) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:21:02 GMTCullinan Therapeutics reports Q2 2026 net loss of $53.7M, cash and investments $356.0M - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTClariant AG Revenue Breakdown – SIX:CLN - TradingViewTradingView · Mon, 03 Aug 2026 17:08:13 GMTREG - Technology Minerals - Settlement of CLG Convertible Loan Notes - TradingViewTradingView · Mon, 03 Aug 2026 06:00:00 GMTCLN Energy Limited Revenue Breakdown – BSE:CLN - TradingViewTradingView · Sun, 02 Aug 2026 06:49:50 GMTCity of London Investment Trust PLC Revenue Breakdown – GETTEX:CLN - TradingViewTradingView · Sat, 01 Aug 2026 09:04:57 GMTCLN: Strong Q2 results and improved cash flow support stable 2026 outlook despite ongoing volatility - TradingViewTradingView · Fri, 31 Jul 2026 13:16:40 GMTClariant confirme ses objectifs 2026 - TradingViewTradingView · Fri, 31 Jul 2026 05:33:00 GMT